Ignite Creation Date:
2024-05-06 @ 1:47 AM
Last Modification Date:
2024-10-26 @ 11:10 AM
Study NCT ID:
NCT01907009
Status:
TERMINATED
Last Update Posted:
2023-04-19
First Post:
2013-07-22
Brief Title:
A Phase II Study Evaluating Intravenous Melphalan With Autologous Whole Blood Stem Cell Transplantation Over Three Cycles In Patients With Castration-Resistant Prostate Cancer MEL-CAP
Sponsor:
Barts The London NHS Trust
Organization:
Barts The London NHS Trust
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-01
Start Date Type:
None
Primary Completion Date:
2016-12-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-12-22
Completion Date Type:
ACTUAL
First Submit Date:
2013-07-22
First Submit QC Date:
July 22 2013
Study First Post Date:
2013-07-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-04-17
Last Update Post Date:
2023-04-19
Last Update Post Date Type:
ACTUAL